Skip to main content
PMC home page
Gut logoLink to Gut
. 1996 Jan;38(1):79–84. doi: 10.1136/gut.38.1.79

Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats.

C Gustafson-Svärd 1, I Lilja 1, O Hallböök 1, R Sjödahl 1
PMCID: PMC1382983  PMID: 8566864

Abstract

Increased prostaglandin E2 synthesis is considered important in both human and experimental colon carcinogenesis. It is not known, however, which cyclooxygenase isoenzyme is involved. The aim of this study was to compare the content of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in colorectal cancers with the content in normal colonic specimens. Fifteen human colorectal adenocarcinomas, 35 azoxymethane induced colonic tumours from rats, and specimens of normal colon were analysed by reverse transcription and polymerase chain reaction (RT-PCR). It was found that cyclooxygenase-1 and cyclooxygenase-2 mRNA were increased in azoxymethane induced colonic tumours, compared with specimens taken adjacent to the tumours or from the macroscopically normal intestine distant from the tumours. Cyclooxygenase-1 and cyclooxygenase-2 mRNA were increased in specimens from the macroscopically normal intestine of azoxymethane treated animals, compared with colonic specimens from saline treated rats. Cyclooxygenase-2 mRNA, but not cyclooxygenase-1 mRNA, was increased in human colorectal cancers, compared with the adjacent mucosa or macroscopically normal mucosa distant from the tumours. The results suggest that cyclooxygenase-2 is involved in the increased prostaglandin E2 synthesis in colonic cancers, and that activation of this isoenzyme is an early event in colon carcinogenesis. However, cyclooxygenase-1 may also be involved, at least in experimental colon carcinogenesis.

Full text

PDF
79

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett A., Civier A., Hensby C. N., Melhuish P. B., Stamford I. F. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut. 1987 Mar;28(3):315–318. doi: 10.1136/gut.28.3.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  3. Crofford L. J., Wilder R. L., Ristimäki A. P., Sano H., Remmers E. F., Epps H. R., Hla T. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J Clin Invest. 1994 Mar;93(3):1095–1101. doi: 10.1172/JCI117060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DeWitt D. L. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim Biophys Acta. 1991 May 8;1083(2):121–134. doi: 10.1016/0005-2760(91)90032-d. [DOI] [PubMed] [Google Scholar]
  5. Earnest D. L., Hixson L. J., Alberts D. S. Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention. J Cell Biochem Suppl. 1992;16I:156–166. doi: 10.1002/jcb.240501330. [DOI] [PubMed] [Google Scholar]
  6. Earnest D. L., Holubec H., Wali R. K., Jolley C. S., Bissonette M., Bhattacharyya A. K., Roy H., Khare S., Brasitus T. A. Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res. 1994 Oct 1;54(19):5071–5074. [PubMed] [Google Scholar]
  7. Eberhart C. E., Coffey R. J., Radhika A., Giardiello F. M., Ferrenbach S., DuBois R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994 Oct;107(4):1183–1188. doi: 10.1016/0016-5085(94)90246-1. [DOI] [PubMed] [Google Scholar]
  8. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. doi: 10.1016/0092-8674(90)90186-i. [DOI] [PubMed] [Google Scholar]
  9. Feng L., Sun W., Xia Y., Tang W. W., Chanmugam P., Soyoola E., Wilson C. B., Hwang D. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys. 1993 Dec;307(2):361–368. doi: 10.1006/abbi.1993.1601. [DOI] [PubMed] [Google Scholar]
  10. Giovannucci E., Rimm E. B., Stampfer M. J., Colditz G. A., Ascherio A., Willett W. C. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994 Aug 15;121(4):241–246. doi: 10.7326/0003-4819-121-4-199408150-00001. [DOI] [PubMed] [Google Scholar]
  11. Gustafson-Svärd C., Lilja I., Sjödahl R., Tagesson C. Cytosolic phospholipase A2 and cyclooxygenase-2 mediate release and metabolism of arachidonic acid in tumor necrosis factor-alpha-primed cultured intestinal epithelial cells (INT 407). Scand J Gastroenterol. 1995 Oct;30(10):1000–1007. doi: 10.3109/00365529509096345. [DOI] [PubMed] [Google Scholar]
  12. Habib A., Créminon C., Frobert Y., Grassi J., Pradelles P., Maclouf J. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J Biol Chem. 1993 Nov 5;268(31):23448–23454. [PubMed] [Google Scholar]
  13. Hallbök O., Boeryd B., Lilja I., Sjödahl R. Association between permeability of the colonic wall and azoxymethane induced cancer of the colon in rats. Eur J Surg. 1992 Sep;158(9):491–494. [PubMed] [Google Scholar]
  14. Hendrickse C. W., Kelly R. W., Radley S., Donovan I. A., Keighley M. R., Neoptolemos J. P. Lipid peroxidation and prostaglandins in colorectal cancer. Br J Surg. 1994 Aug;81(8):1219–1223. doi: 10.1002/bjs.1800810849. [DOI] [PubMed] [Google Scholar]
  15. Hendrickse C. W., Radley S., Donovan I. A., Keighley M. R., Neoptolemos J. P. Activities of phospholipase A2 and diacylglycerol lipase are increased in human colorectal cancer. Br J Surg. 1995 Apr;82(4):475–478. doi: 10.1002/bjs.1800820415. [DOI] [PubMed] [Google Scholar]
  16. Hla T., Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7384–7388. doi: 10.1073/pnas.89.16.7384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kudo I., Murakami M., Hara S., Inoue K. Mammalian non-pancreatic phospholipases A2. Biochim Biophys Acta. 1993 Nov 3;1170(3):217–231. doi: 10.1016/0005-2760(93)90003-r. [DOI] [PubMed] [Google Scholar]
  18. Lee D. Y., Lupton J. R., Chapkin R. S. Prostaglandin profile and synthetic capacity of the colon: comparison of tissue sources and subcellular fractions. Prostaglandins. 1992 Feb;43(2):143–164. doi: 10.1016/0090-6980(92)90083-6. [DOI] [PubMed] [Google Scholar]
  19. Lilja I., Dimberg J., Sjödahl R., Tagesson C., Gustafson-Svärd C. Effects of endotoxin and dexamethasone on group I and II phospholipase A2 in rat ileum and stomach. Gut. 1994 Jan;35(1):40–45. doi: 10.1136/gut.35.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lilja I., Smedh K., Olaison G., Sjödahl R., Tagesson C., Gustafson-Svärd C. Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis. Gut. 1995 Sep;37(3):380–385. doi: 10.1136/gut.37.3.380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mereto E., Frencia L., Ghia M. Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine. Cancer Lett. 1994 Jan 15;76(1):5–9. doi: 10.1016/0304-3835(94)90127-9. [DOI] [PubMed] [Google Scholar]
  22. Metzger U., Meier J., Uhlschmid G., Weihe H. Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer. Dis Colon Rectum. 1984 Jun;27(6):366–369. doi: 10.1007/BF02553001. [DOI] [PubMed] [Google Scholar]
  23. Mikkelsen H. B., Rumessen J. J., Qvortrup K. Prostaglandin H synthase immunoreactivity in human gut. An immunohistochemical study. Histochemistry. 1991;96(4):295–299. doi: 10.1007/BF00271349. [DOI] [PubMed] [Google Scholar]
  24. Murata K., Egami H., Kiyohara H., Oshima S., Kurizaki T., Ogawa M. Expression of group-II phospholipase A2 in malignant and non-malignant human gastric mucosa. Br J Cancer. 1993 Jul;68(1):103–111. doi: 10.1038/bjc.1993.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Muscat J. E., Stellman S. D., Wynder E. L. Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer. 1994 Oct 1;74(7):1847–1854. doi: 10.1002/1097-0142(19941001)74:7<1847::aid-cncr2820740704>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  26. Neoptolemos J. P., Husband D., Imray C., Rowley S., Lawson N. Arachidonic acid and docosahexaenoic acid are increased in human colorectal cancer. Gut. 1991 Mar;32(3):278–281. doi: 10.1136/gut.32.3.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Nicholson M. L., Neoptolemos J. P., Clayton H. A., Talbot I. C., Bell P. R. Increased cell membrane arachidonic acid in experimental colorectal tumours. Gut. 1991 Apr;32(4):413–418. doi: 10.1136/gut.32.4.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Pugh S., Thomas G. A. Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2. Gut. 1994 May;35(5):675–678. doi: 10.1136/gut.35.5.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rao C. V., Desai D., Simi B., Kulkarni N., Amin S., Reddy B. S. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res. 1993 Sep 15;53(18):4182–4188. [PubMed] [Google Scholar]
  30. Rao C. V., Simi B., Reddy B. S. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis. 1993 Nov;14(11):2219–2225. doi: 10.1093/carcin/14.11.2219. [DOI] [PubMed] [Google Scholar]
  31. Reddy B. S., Rao C. V., Rivenson A., Kelloff G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis. 1993 Aug;14(8):1493–1497. doi: 10.1093/carcin/14.8.1493. [DOI] [PubMed] [Google Scholar]
  32. Reddy B. S., Tokumo K., Kulkarni N., Aligia C., Kelloff G. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis. 1992 Jun;13(6):1019–1023. doi: 10.1093/carcin/13.6.1019. [DOI] [PubMed] [Google Scholar]
  33. Rigas B., Goldman I. S., Levine L. Altered eicosanoid levels in human colon cancer. J Lab Clin Med. 1993 Nov;122(5):518–523. [PubMed] [Google Scholar]
  34. Rzymkiewicz D., Leingang K., Baird N., Morrison A. R. Regulation of prostaglandin endoperoxide synthase gene expression in rat mesangial cells by interleukin-1 beta. Am J Physiol. 1994 Jan;266(1 Pt 2):F39–F45. doi: 10.1152/ajprenal.1994.266.1.F39. [DOI] [PubMed] [Google Scholar]
  35. Schreinemachers D. M., Everson R. B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 1994 Mar;5(2):138–146. doi: 10.1097/00001648-199403000-00003. [DOI] [PubMed] [Google Scholar]
  36. Singh J., Kulkarni N., Kelloff G., Reddy B. S. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis. Carcinogenesis. 1994 Jul;15(7):1317–1323. doi: 10.1093/carcin/15.7.1317. [DOI] [PubMed] [Google Scholar]
  37. Stopera S. A., Murphy L. C., Bird R. P. Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer. Carcinogenesis. 1992 Nov;13(11):2081–2085. doi: 10.1093/carcin/13.11.2081. [DOI] [PubMed] [Google Scholar]
  38. Yamaguchi A., Ishida T., Nishimura G., Katoh M., Miyazaki I. Investigation of colonic prostaglandins in carcinogenesis in the rat colon. Dis Colon Rectum. 1991 Jul;34(7):572–576. doi: 10.1007/BF02049897. [DOI] [PubMed] [Google Scholar]
  39. Yamashita S. Studies on changes of colonic mucosal PGE2 levels and tissue localization in experimental colitis. Gastroenterol Jpn. 1993 Apr;28(2):224–235. doi: 10.1007/BF02779224. [DOI] [PubMed] [Google Scholar]
  40. Yamashita S., Yamashita J., Ogawa M. Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency. Br J Cancer. 1994 Jun;69(6):1166–1170. doi: 10.1038/bjc.1994.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ying Z., Tojo H., Komatsubara T., Nakagawa M., Inada M., Kawata S., Matsuzawa Y., Okamoto M. Enhanced expression of group II phospholipase A2 in human hepatocellular carcinoma. Biochim Biophys Acta. 1994 May 25;1226(2):201–205. doi: 10.1016/0925-4439(94)90029-9. [DOI] [PubMed] [Google Scholar]
  42. Yokoyama C., Tanabe T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Commun. 1989 Dec 15;165(2):888–894. doi: 10.1016/s0006-291x(89)80049-x. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES